Übermäßige Einschränkungen der Bewegung von Personen und Gütern könnten die Realwirtschaft gefährden.
Phases 3 studies of Remdesivir made by U.S. pharmaceutical giant Gilead could take place in South Korea soon.
Syria’s government has started testing in areas in the rest of the country, although has not yet reported a case to the WHO. Turkey to the north confirmed its first case last week and Iraq has at least 93 confirmed cases.
In the Event 201 Simulation of a Coronavirus Pandemic, a 15% collapse of financial markets had been “simulated”.
It was not “predicted” according to the organizers and sponsors of the event.
Private sector initiative. Participation of corporate execs, foundations, financial institutions, Banks, Big Pharma, CIA, CDC, No health officials on behalf of national governments or the WHO. The simulation exercise was held on the same day as the opening of the CISM World Militaty Sports Games in Wuhan.
The head of the World Health Organization says Europe, not China, is now the epicenter of the world’s coronavirus pandemic.
Director-General Tedros Adhanom Ghebreyesus told reporters in Geneva that “more cases are now being reported every day than were reported in China at the height of its epidemic.”
Israel based Vaxil Bio Ltd. announced an update to the Company’s press release dated February 13, 2020, regarding the possible identification of a novel coronavirus vaccine candidate, Vaccine Candidate.
Vaxil said in a newly published press release on February 18, 2020, the Vaccine Candidate is based on unique and patent-protected signal peptide technology, utilizing Vaxil’s proprietary VaxHit™ bioinformatics platform.
Die WHO hat die Coronavirus-Epidemie zum internationalen Gesundheitsnotstand erklärt. Eine solche Krisenmaßnahme hat die Organisation bereits in anderen Fällen ausgerufen. Aber was bedeutet das eigentlich?
TDR has partnered with the World Health Organization, the International Atomic Energy Agency and the Food and Agriculture Organization to develop a pilot program for countries interested in using SIT on mosquitoes to test the impact on disease transmission.